Orenitram (Avera McKennan Hospital)


Welcome to the PulseAid listing for the Orenitram drug offered from Avera McKennan Hospital. This Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Avera McKennan Hospital
NON-PROPRIETARY NAME: treprostinil
SUBSTANCE NAME: TREPROSTINIL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE]
ROUTE: ORAL
DOSAGE FORM: TABLET, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-07-20
END MARKETING DATE: 0000-00-00


Orenitram HUMAN PRESCRIPTION DRUG Details:

Item DescriptionOrenitram from Avera McKennan Hospital
LABELER NAME: Avera McKennan Hospital
DEA SCHEDULE:
ACTIVE STRENGTH: 2.5(mg/1)
START MARKETING DATE: 2016-07-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69189-0676_326259ad-5289-4cd7-bf8c-6913e4f867db
PRODUCT NDC: 69189-0676
APPLICATION NUMBER: NDA203496

Other TREPROSTINIL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalOrenitram
United Therapeutics Corp.TYVASO
United Therapeutics CorporationRemodulin